Author

Antanas Gulbinas

COMPARISON OF PBMC FUNCTIONS AND AHR, ELAVL-1 EXPRESSION IN PANCREATIC CANCER VS HEALTHY PATIENTS
COMPARISON OF PBMC FUNCTIONS AND AHR, ELAVL-1 EXPRESSION IN PANCREATIC CANCER VS HEALTHY PATIENTS

SILENCING OF AHR AND ELAVL1 GENES INFLUENCES POST-TRANSCRIPTIONAL EXPRESSION OF EACH OTHER AND CHEMORESISTANCE OF PANCREATIC CANCER CELLS, IN VITRO
SILENCING OF AHR AND ELAVL1 GENES INFLUENCES POST-TRANSCRIPTIONAL EXPRESSION OF EACH OTHER AND CHEMORESISTANCE OF PANCREATIC CANCER CELLS, IN VITRO

Antanas Gulbinas  et al.

COMPARISON OF PBMC FUNCTIONS AND AHR, ELAVL-1 EXPRESSION IN PANCREATIC CANCER VS HEALTHY PATIENTS
COMPARISON OF PBMC FUNCTIONS AND AHR, ELAVL-1 EXPRESSION IN PANCREATIC CANCER VS HEALTHY PATIENTS

Antanas Gulbinas  et al.

THE EMT PROGRAM PROTEINS HAVE RELEVANT IMPACT ON CLINICAL OUTCOMES OF PANCREATIC CANCER PATIENTS THAT MIGHT BE DEPENDENT ON HUR AND AHR POST-TRANSCRIPTIONAL REGULATION
THE EMT PROGRAM PROTEINS HAVE RELEVANT IMPACT ON CLINICAL OUTCOMES OF PANCREATIC CANCER PATIENTS THAT MIGHT BE DEPENDENT ON HUR AND AHR POST-TRANSCRIPTIONAL REGULATION

Antanas Gulbinas  et al.

FUNCTION CHANGES IN HEALTHY PARTICIPANTS PBMCS AFTER CO-CULTIVATION WITH PANCREATIC CANCER CELL
FUNCTION CHANGES IN HEALTHY PARTICIPANTS PBMCS AFTER CO-CULTIVATION WITH PANCREATIC CANCER CELL

Antanas Gulbinas  et al.

TO BE, OR NOT BE: HAMLET (HUMAN ALPHA-LACTALBUMIN MADE LETHAL TO TUMOR CELLS) TUMORICIDAL ACTIVITY IN COLORECTAL CANCER CELL LINES WITH DIFFERENT MUTATION STATUS IN VITRO
TO BE, OR NOT BE: HAMLET (HUMAN ALPHA-LACTALBUMIN MADE LETHAL TO TUMOR CELLS) TUMORICIDAL ACTIVITY IN COLORECTAL CANCER CELL LINES WITH DIFFERENT MUTATION STATUS IN VITRO

Antanas Gulbinas  et al.

Item 1 - 6 / 6
1